Emprise Bank’s Eli Lilly LLY Stock Holding History

Emprise Bank’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$282K	Hold	244	–	–	0.11%	83
2026 Q2	$293K	Hold	244	–	–	0.11%	83
2026 Q1	$224K	Hold	244	–	–	0.09%	97
2025 Q4	$262K	Sell	244 -100	-29%	-$95.6K	0.11%	91
2025 Q3	$262K	Hold	344	–	–	0.11%	90
2025 Q2	$268K	Sell	344 -204	-37%	-$159K	0.13%	84
2025 Q1	$453K	Sell	548 -28	-5%	-$23.3K	0.24%	65
2024 Q4	$445K	Sell	576 -28	-5%	-$23.2K	0.25%	68
2024 Q3	$535K	Sell	604 -456	-43%	-$410K	0.31%	61
2024 Q2	$960K	Sell	1,060 -24	-2%	-$19.2K	0.59%	41
2024 Q1	$843K	Buy	+1,084	New	+$771K	0.57%	45

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Emprise Bank's LLY Position: Q3 2026 in Review

Emprise Bank held its Eli Lilly (LLY) position steady in Q3 2026 at 244 shares worth $282K. The position accounts for 0.11% of the portfolio, ranked #83.

Emprise Bank first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $960K in Q2 2024. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Emprise Bank held 244 shares of Eli Lilly worth $282K as of Q3 2026.
Emprise Bank left its Eli Lilly share count unchanged in Q3 2026.
Eli Lilly made up 0.11% of Emprise Bank's portfolio in Q3 2026, its #83 holding.
Emprise Bank first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
Emprise Bank's Eli Lilly position peaked at $960K in Q2 2024.
4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Emprise Bank's 13F filing for Q3 2026, filed 7 Oct 2026.